Literature DB >> 26586126

Therapeutic Outlook of Pyrazole Analogs: A Mini Review.

Swastika Ganguly1, Sony K Jacob1.   

Abstract

BACKGROUND: Pyrazole is one of the excellent structural motifs in medicinal chemistry. Various physiological and therapeutic possibilities have been exploited by incorporating different pharmacophoric groups in the pyrazole moiety.
OBJECTIVE: This has opened a new arena of pyrazole analogs that can be developed into medicinal agents such as anti-inflammatory, analgesic, antipyretic, antiviral, antibacterial, anticancer, anticonvulsant, hypoglycemic, carbonic anhydrase inhibitors, mono amino oxidase (MAO) inhibitors, etc. Though, pyrazole analogs have proven their clinical efficacy as different pharmacological agents, a few of them have been withdrawn from the market due to their side effects. Thus, research on potential new drug candidates bearing the pyrazole moiety with lesser side effects has fairly increased over the last few years.
CONCLUSION: This review explores diverse pharmacological activities exhibited by pyrazole analogs reported recently, which may be of great help for researchers in the area of drug discovery to understand the current scenario of pyrazole based compounds and to design and develop newer drug candidates with improved efficacy. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  Analgesic; anti-inflammatory; antibacterial; anticancer; antipyretic; antiviral; pyrazole

Mesh:

Substances:

Year:  2017        PMID: 26586126     DOI: 10.2174/1389557516666151120115302

Source DB:  PubMed          Journal:  Mini Rev Med Chem        ISSN: 1389-5575            Impact factor:   3.862


  2 in total

1.  Pyrazolyl Thioureas and Carbothioamides with an NNSN Motif against MSSA and MRSA.

Authors:  Anjana Delpe-Acharige; Man Zhang; Kayla Eschliman; Alex Dalecki; Obdulia Covarrubias-Zambrano; Azriel Minjarez-Almeida; Tejaswi Shrestha; Tanji Lewis; Fatimah Al-Ibrahim; Sophia Leonard; Riana Roberts; Anteneh Tebeje; Aruni P Malalasekera; Hongwang Wang; Madumali Kalubowilage; Frank Wolschendorf; Olaf Kutsch; Stefan H Bossmann
Journal:  ACS Omega       Date:  2021-02-22

2.  Pyrazole Incorporated New Thiosemicarbazones: Design, Synthesis and Investigation of DPP-4 Inhibitory Effects.

Authors:  Belgin Sever; Hasan Soybir; Şennur Görgülü; Zerrin Cantürk; Mehlika Dilek Altıntop
Journal:  Molecules       Date:  2020-10-28       Impact factor: 4.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.